Cancer Uses Cell Death Proteins to Survive Treatment and Regrow
Researchers at UC San Diego have found a paradoxical new way in which cancer cells survive and regrow after targeted therapy: by hijacking a protein involved in cell death.
Health & Behavior
The Latest
UC San Diego Researchers Expand Virus-Based Treatment Options for Antibiotic-Resistant Infections
Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and their colleagues have developed a new method to combat antibiotic-resistant bacteria
Precision Therapy Could Stop Breast Cancer at the Source
UC San Diego researchers have developed a new targeted therapy for triple-negative breast cancer, the most difficult-to-treat subtype of the disease.
When Life Imitates Art: Google Searches for Anxiety Drug Spike During Run of The White Lotus TV Show
A UC San Diego study suggests that the depiction of lorazepam use on Season 3 of The White Lotus TV series sparked 1.6 million extra Google searches for information about the benzodiazepine drug, including how to acquire it online.
Endowed Chair in Circadian Biology and Medicine Established at UC San Diego
The University of California San Diego has announced that Amir Zarrinpar, M.D., Ph.D., has been appointed as the inaugural holder of the Stuart and Barbara L. Brody Endowed Chair in Circadian Biology and Medicine.
GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%
Trending Stories
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
